If a child’s life was in danger you would do something, wouldn’t you?
The Children’s Brain Tumor Project Weill Cornell Medicine is proud to present this powerful public service announcement (PSA). The PSA, produced and funded by the generosity of DDB Health, is intended to raise awareness of the traumatic outcomes for far too many children diagnosed with brain tumors every year, and demand action by encouraging viewers to donate.
You can do something to help. The generous gifts of our supporters allow our neuroscientists/researchers to continue their important work.
If a child’s life was in danger you would do something, wouldn’t you?
The “Do Something” campaign was designed to encourage action against pediatric brain tumors.
LATEST NEWS
Our Results are Powered by Families
Dr. Souweidane 2026 Conferences
May 20, 2026 - Dr. Souweidane was recently invited to present on advances in surgical neurooncology and the field’s shift toward more precise and innovative approaches at 3 national conferences/meetings.
CBTP Welcomes Summer Interns 2026
February 1, 2026 - Weill Cornell Medicine investigators have received a $100,000 grant from the GC Global consortium to study diffuse pediatric brain tumors, including gliomatosis cerebri. The project will develop standardized tools combining imaging and molecular data to better understand how these tumors spread through the brain.
No Laughing Matter 2026 Honors Gretchen Scott
May 28, 2026 - The 2026 Comedy Gala will be held on October 22 at the New York Athletic Club, bringing together 300 distinguished guests in support of pediatric brain tumor research. This year’s gala will honor designer Gretchen Scott for her early and lasting connection to Elizabeth’s Hope and her support of our mission at the CBTP.
AACR ADVOCACY DAYS 2026
May 14, 2026 -CBTP Program Director Cindy Campbell joined the American Association for Cancer Research (AACR) and colleagues to advocate for sustained federal investment in cancer research. They met with NYS representatives to highlight the importance of continued support for scientific discovery.
CED Trial Funding from Cure Starts Now
APRIL 15, 2026 -Dr. Mark Souweidane has received a grant from The Cure Starts Now Foundation and partners to support a Phase 1a clinical trial testing 177Lu-DTPA-omburtamab in children and young adults with DMG, including DIPG. This next-generation approach combines precision radioimmunotherapy with real-time imaging to evaluate safety, dosing, and drug distribution in the tumor.
ABOUT US
Our unique approach is based on four pillars of cutting-edge research.
ABOUT US
Our unique approach is based on four pillars of cutting-edge research.
POWERED BY FAMILIES
The project is “powered by families” – donations come from the families, friends, and supporters of the children, adolescents, and young adults diagnosed with these tumors. In the absence of major funding from government agencies or major foundations, the Children’s Brain Tumor Project is supported by those with the most at stake in this battle.
Research News
Peer-reviewed publications validate research findings because they subject the authors scholarly work to a high level of scrutiny from other experts in the field who evaluate whether an article is suitable for publication. The sheer volume of published work from the team at the Children’s Brain Tumor Project is a testament to the hard work and dedication of our lab team.
Other research news such as awards, collaborations, annual reports and point-of-view articles can also be found here.